Hengdian Group
Dongyang, China· Est.
A diversified Chinese conglomerate with pharmaceutical operations spanning APIs, CDMO, finished drugs, medical devices, and services.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A diversified Chinese conglomerate with pharmaceutical operations spanning APIs, CDMO, finished drugs, medical devices, and services.
Broad/Unspecified
Technology Platform
Traditional small molecule synthesis and manufacturing with emphasis on green chemistry principles for API and intermediate production.
Opportunities
Growth in China's pharmaceutical manufacturing sector and expansion of CDMO services globally, particularly with emphasis on environmentally sustainable production methods.
Risk Factors
Limited visibility into innovative pipeline, potential margin pressure in competitive generic markets, and dependence on broader conglomerate structure rather than focused pharmaceutical strategy.
Competitive Landscape
Competes with other Chinese pharmaceutical manufacturers and CDMO providers like WuXi AppTec and Pharmaron, differentiated by integrated operations across APIs, finished drugs, and medical services within a diversified industrial group.